RXO, Inc. (RXO)
| Market Cap | 4.68B +130.5% |
| Revenue (ttm) | 6.54B +10.1% |
| Net Income | -88.00M |
| EPS | -0.52 |
| Shares Out | 164.95M |
| PE Ratio | n/a |
| Forward PE | 54.95 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,966,346 |
| Open | 28.26 |
| Previous Close | 28.42 |
| Day's Range | 28.26 - 28.51 |
| 52-Week Range | 10.43 - 29.90 |
| Beta | 1.85 |
| Analysts | Hold |
| Price Target | 29.83 (+5.22%) |
| Earnings Date | Oct 29, 2026 |
About RXO
RXO, Inc. engages in truck brokerage business in the United States, Canada, Mexico, Asia, and Europe. It offers truckload freight brokering services. The company also provides asset-light managed transportation and last mile services, as well as freight forwarding services, including facilitation of ocean and air transportation, customs brokerage, and additional domestic services including middle mile. RXO, Inc. was incorporated in 2022 and is headquartered in Charlotte, North Carolina.
Financial Performance
In 2025, RXO, Inc.'s revenue was $5.74 billion, an increase of 26.20% compared to the previous year's $4.55 billion. Losses were -$100.00 million, -65.52% less than in 2024.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for RXO stock is "Hold." The 12-month stock price target is $29.83, which is an increase of 5.22% from the latest price.
News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)
BALA CYNWYD, Pa., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j...
RXO Inc. price target raised to $30.25 from $23 at UBS
UBS raised the firm’s price target on RXO Inc. (RXO) to $30.25 from $23 and keeps a Neutral rating on the shares.
RXO Inc. price target raised to $30 from $19 at Susquehanna
Susquehanna raised the firm’s price target on RXO Inc. (RXO) to $30 from $19 and keeps a Neutral rating on the shares. The firm cites the pending takeover for the…
RXO, Inc. Earnings release: Q3 2026
RXO, Inc. released its Q3 2026 earnings on October 29, 2026, summarizing the period's financial results.
RXO, Inc. Quarterly report: Q3 2026
RXO, Inc. has published its Q3 2026 quarterly earnings report on October 29, 2026.
RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains
CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO) today reported strong third-quarter financial results. RXO Chairman and CEO Drew Wilkerson said, “We exceeded the high end of our third...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j...
C.H. Robinson price target lowered to $160 from $190 at BMO Capital
BMO Capital lowered the firm’s price target on C.H. Robinson (CHRW) to $160 from $190 and keeps a Market Perform rating on the shares. The company’s acquisition of RXO (RXO)…
RXO Inc. price target raised to $30 from $28 at Truist
Truist raised the firm’s price target on RXO Inc. (RXO) to $30 from $28 and keeps a Buy rating on the shares as part of a broader research note previewing…
RXO Inc. moved to No Rating at BofA
BofA moved to No Rating on RXO Inc. (RXO) after C.H. Robinson (CHRW) announced a deal to acquire the company for $30.25 per share. Given the deal announcement, RXO shares…
C.H. Robinson price target lowered to $217 from $237 at Evercore ISI
Evercore ISI lowered the firm’s price target on C.H. Robinson (CHRW) to $217 from $237 and keeps an Outperform rating on the shares. The RXO Inc. (RXO) acquisition may provide…
Freight Broker C.H. Robinson to Buy Smaller Rival RXO
Plus, the U.S. will temporarily allow highway sales of dyed diesel, and Persian Gulf oil producers pay millions to move crude.
RXO Inc. price target raised to $30 from $23 at Citi
Citi raised the firm’s price target on RXO Inc. (RXO) to $30 from $23 and keeps a Neutral rating on the shares after the company agreed to be acquired by…
RXO Inc. price target raised to $30 from $23 at Wells Fargo
Wells Fargo raised the firm’s price target on RXO Inc. (RXO) to $30 from $23 and keeps an Equal Weight rating on the shares. The firm understands concerns around the…
RXO Inc. upgraded to Neutral from Underweight at JPMorgan
JPMorgan upgraded RXO Inc. (RXO) to Neutral from Underweight with a price target of $30, up from $22, after the company agreed to be acquired by C.H. Robinson (CHRW) for…
RXO Inc. downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Fadi Chamoun downgraded RXO Inc. (RXO) to Market Perform from Outperform with a price target of $30.25, down from $35, after the company agreed to be acquired…
RXO Inc. downgraded to Hold from Buy at Jefferies
Jefferies downgraded RXO Inc. (RXO) to Hold from Buy with an unchanged price target of $30 after the company entered into an agreement to be acquired by C.H. Robinson for…
RXO Inc. upgraded to Hold from Sell at TD Cowen
TD Cowen upgraded RXO Inc. (RXO) to Hold from Sell with a $30.25 price target after the company entered into an agreement to be acquired by C.H. Robinson for $30.25…
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD)
BALA CYNWYD, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j...
Monday's First Moves: CHRW & RXO Merger, PTC Acquisition, DKNG Upgrade
C.H. Robinson (CHRW) seeks to strengthen its transportation empire with an acquisition of RXO (RXO). As Diane King Hall points out, it's not the only acquisition moving Wall Street on Monday, highligh...
RXO stock soars as CH Robinson acquires truck broker for $5.8B
CH Robinson Worldwide has agreed to acquire truck broker RXO for about $5.8 billion in cash and stock, creating a logistics company with an enterprise value of more than $25 billion as the third-party...
C.H. Robinson to Buy RXO for About $5 Billion
C.H. Robinson Worldwide has agreed to buy truck broker RXO for around $5 billion in cash and stock in a deal that would create a logistics company with an enterprise value topping $25 billion.
RXO Stock Soars. C.H. Robinson Is Buying It for Implied Value of $5.8 Billion.
C.H. Robinson will acquire RXO in a deal with an implied value of $5.8 billion.
RXO Executive Named a Finalist in 2026 Stevie® Awards for Women in Business
CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO), a leading provider of asset-light transportation solutions, announced today that Chief Technology Officer Alyssa Myers was named a fin...
RXO, Inc. Transcript: Morgan Stanley's 14th Annual Laguna Conference
Q3 truckload volume was expected to grow low to mid-single-digits YoY, with stronger spot profitability and share gains despite weak freight demand. Management sees supply tightening into 2027 and is scaling technology, Coyote integration and adjacent businesses.